Evidence map›Paper›PMID 31750078›Full record

ArticleAnnals of global health2019

HIV Research Training Partnership of the University of Zambia and Vanderbilt University: Features and Early Outcomes.

Wilbroad Mutale, Selestine Nzala, Holly M Cassell, Marie H Martin, Benjamin H Chi, Mulenga Mukanu, Perfect Shankalala, John R Koethe, Douglas C Heimburger

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Wilbroad MutaleUniversity of Zambia, Lusaka, ZM.
Selestine NzalaUniversity of Zambia, Lusaka, ZM.
Holly M CassellVanderbilt University Medical Center and Vanderbilt Institute for Global Health, Nashville, Tennessee, US.
Marie H MartinVanderbilt University Medical Center and Vanderbilt Institute for Global Health, Nashville, Tennessee, US.
Benjamin H ChiUniversity of North Carolina, Chapel Hill, North Carolina, US.
Mulenga MukanuUniversity of Zambia, Lusaka, ZM.
Perfect ShankalalaUniversity of Zambia, Lusaka, ZM.
John R KoetheVanderbilt University Medical Center and Vanderbilt Institute for Global Health, Nashville, Tennessee, US.
Douglas C HeimburgerUniversity of Zambia, Lusaka, ZM.
University of Zambia · ZMVanderbilt University Medical Center · USVanderbilt Health · USUniversity of North Carolina at Chapel Hill · US

Funding

UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)D43TW009744 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, MUTALE, WILBROAD · 2015 to 2025
$3.2M
FIC NIH HHS D43 TW009744
6 · The paper itself

Abstract

Background: Despite the burden of HIV being highest in sub-Saharan Africa (SSA), research expertise and capacity to address scientific questions regarding complications of HIV and ART, especially chronic non-communicable conditions, is limited in the region. The comorbidities prevalent in persons with HIV are mediated through diverse mechanisms, many of which can be context or region-specific and are yet to be elucidated. The phenotype, risk factors, and effective interventions for these conditions may differ between populations and settings, and therefore there is an urgent need for research to help understand these processes and how to best address them in SSA. Here, we report the research capacity building activities in SSA conducted by the University of Zambia (UNZA)-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP), drawing lessons and challenges for a wide global health audience. Methods: We reviewed program data and conducted interviews with program leaders and participants to understand and document the progress and outcomes of the partnership. We report the program's early achievements, highlighting drivers and challenges. Results: Between 2015 and 2019, UVP made substantial progress on its goals of training new UNZA PhD scientists to investigate complex nutritional and metabolic factors related to long-term HIV complications and comorbidities. The program has supported 11 UNZA PhD students with dual UNZA-Vanderbilt mentorship; three have graduated, and other candidates are progressing in their PhD studies. The project also supported institutional capacity through UNZA faculty participation in Vanderbilt grant writing workshops, with strong success in obtaining grants among those who participated. UVP also supported development of greater structure to UNZA's PhD program and a mentorship curriculum, both now adopted by UNZA. The major drivers for success included UVP's alignment of goals between UNZA and Vanderbilt, and local institutional ownership. The longstanding history of collaborations between the two institutions contributed substantially to alignment and mutual support of UVP's goals. Several challenges were noted, including limits on direct research funding for students and a relatively small pool of funded investigators at UNZA. Conclusions: Despite some challenges, UVP has achieved positive outcomes over its first four years. Longstanding partnerships and local institutional ownership were the main drivers. We expect the challenges to mitigated as the project continues and produces more UNZA researchers and teams and more funded projects, collectively building the local research community. With continued resources and clear focus, we expect that UNZA's investigators and partners will attract research funding and generate high-impact research outputs across a broad range of studies in HIV as well as newer threats from non-communicable conditions experienced by long-term survivors of HIV and by the general population.

Indexed as

Biomedical ResearchCapacity BuildingUniversitiesAntiretroviral Therapy, Highly ActiveHIV InfectionsHumansInternational CooperationMentorsProgram DevelopmentResearch PersonnelResearch Support as TopicTraining SupportUnited StatesZambia

Identifiers

PMID31750078
PMCPMC6838769
OpenAlexW2987647769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.